If health tech challenges were mountains, patient medical records would be a kind of Everest, with the gear of tech giants and digital health startups alike lying abandoned along its precipitous path. Now, a new contender is making the climb.
The company, called Seqster (pronounced “seek-ster”), on Thursday raised its first public funding, a $12 million Series A round led by Omni Health Holdings, with additional investment from Takeda Digital Ventures and Anne Wojcicki, founder and chief executive officer of 23andMe. The data-syncing platform lets patients combine health information from electronic health records, wearables, DNA sequencing platforms, and other sources.
About the Author Reprints
